News Focus
News Focus
icon url

Rob777

09/21/21 4:03 PM

#355047 RE: lizzy241 #355044

lizzy241- A few thoughts. That was a suberb commercial.
And the people behind the company know exactly what they are doing. I totally missed that company until a saw the Barron's article. Strange because I follow Dr Bhatt. With Amarin though, they have to put the warnings in. Blame a lot of that on MRC and his citizens petitions that were partially responsible for the adcom. The panel recommended Vascepa but a lot urged warnings to go along with the approval.
icon url

sstyles

09/21/21 4:54 PM

#355051 RE: lizzy241 #355044

If anyone has Karim's email address they should email it to him.

I emailed investor relations in the past but they don't respond so I'm not going to waste my time. Is anyone even working in IR? No wonder there is tepid interest to own the stock.

I haven't seen an Amarin commercial in months.

btw: if you want to see a management team who knows how to launch a product watch this presentation: https://wsw.com/webcast/oppenheimer16/plxp/2825452

Both PLX and Amarin have heart medications...and Dr. Bhatt is involved with both. One company is moving in the right direction and the other seems to be constantly in stealth mode.

Go figure